Avapro and Cozaar are now the first drugs APPROVED for treating kidney disease in patients with type 2 diabetes and hypertension
Avapro and Cozaar are now the first drugs APPROVED for treating kidney disease in patients with type 2 diabetes and hypertension.
For years clinicians used ACE inhibitors for these patients. But no ACE inhibitor is actually APPROVED for this use.
Avapro (irbesartan) and Cozaar (losartan) slow progression of kidney disease...similar to ACE inhibitors. Other angiotensin receptor blockers probably work too.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 300+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote